While several receptors have been targeted on-chip by us and others in previous work using protein-based agents [8,9,24,25], we report, for the first time, successful targeting of the well-established tumor target CAIX on-chip by CAIX-specific affibodies. The gene discussed is CA9; the disease is neoplasm.